Chuanming Xu

1.5k total citations
47 papers, 1.2k citations indexed

About

Chuanming Xu is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Chuanming Xu has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 24 papers in Endocrinology, Diabetes and Metabolism and 19 papers in Molecular Biology. Recurrent topics in Chuanming Xu's work include Renin-Angiotensin System Studies (25 papers), Hormonal Regulation and Hypertension (22 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (14 papers). Chuanming Xu is often cited by papers focused on Renin-Angiotensin System Studies (25 papers), Hormonal Regulation and Hypertension (22 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (14 papers). Chuanming Xu collaborates with scholars based in China, United States and Singapore. Chuanming Xu's co-authors include Tianxin Yang, Wayne A. Border, J. Zhang, Nancy A. Noble, Yü Huang, Aihua Lu, Fei Wang, Xiaohan Lu, Hui Fang and Li Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and The FASEB Journal.

In The Last Decade

Chuanming Xu

44 papers receiving 1.2k citations

Peers

Chuanming Xu
Xiaohan Lu United States
Elaine Hillas United States
Sammy W.M. Shiu Hong Kong
Xiaohan Lu United States
Chuanming Xu
Citations per year, relative to Chuanming Xu Chuanming Xu (= 1×) peers Xiaohan Lu

Countries citing papers authored by Chuanming Xu

Since Specialization
Citations

This map shows the geographic impact of Chuanming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanming Xu more than expected).

Fields of papers citing papers by Chuanming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanming Xu. The network helps show where Chuanming Xu may publish in the future.

Co-authorship network of co-authors of Chuanming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanming Xu. A scholar is included among the top collaborators of Chuanming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanming Xu. Chuanming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yuting, Jianan Sun, Yue Jing, et al.. (2025). VEGF-B-mediated myofiber types involved in high-fat diet-induced hyperglycemia through PKA-NFATs signaling pathway. Stem Cell Research & Therapy. 16(1). 336–336.
2.
Yi, Xiaoli, et al.. (2024). Principle role of the (pro)renin receptor system in cardiovascular and metabolic diseases: An update. Cellular Signalling. 124. 111417–111417. 4 indexed citations
3.
Liu, Chunju, Shanshan Song, Xiaoli Yi, et al.. (2024). Soluble (pro)renin receptor as a novel laboratory biomarker of atherosclerosis. Acta Biochimica et Biophysica Sinica. 57(3). 501–504. 3 indexed citations
4.
Guo, Huijun, et al.. (2024). Saponins from Allii Macrostemonis Bulbus attenuate atherosclerosis by inhibiting macrophage foam cell formation and inflammation. Scientific Reports. 14(1). 12917–12917. 7 indexed citations
5.
Zhang, Yifeng, et al.. (2024). Saponins from Allium macrostemon Bulbs Attenuate Endothelial Inflammation and Acute Lung Injury via the NF-κB/VCAM-1 Pathway. Molecules. 29(6). 1239–1239. 5 indexed citations
6.
Liu, Chunju, Xiaoli Yi, Shanshan Song, et al.. (2024). Decreased plasma ELABELA level as a novel screening indicator for heart failure: a cohort and observational study. Scientific Reports. 14(1). 11333–11333. 3 indexed citations
9.
Xu, Chuanming, et al.. (2023). Differential regulation of autophagy on urine-concentrating capability through modulating the renal AQP2 expression and renin-angiotensin system in mice. American Journal of Physiology-Renal Physiology. 325(4). F503–F518. 2 indexed citations
10.
Yi, Xiaoli, Chuanming Xu, Huiru Yang, et al.. (2023). Tiliroside Protects against Lipopolysaccharide-Induced Acute Kidney Injury via Intrarenal Renin–Angiotensin System in Mice. International Journal of Molecular Sciences. 24(21). 15556–15556. 6 indexed citations
11.
12.
Ouyang, Xin & Chuanming Xu. (2022). Targeting the (pro)renin receptor in cancers: from signaling to pathophysiological effects. Journal of Cancer Research and Clinical Oncology. 149(6). 2595–2605. 2 indexed citations
13.
Xu, Chuanming, et al.. (2021). The Soluble (Pro)Renin Receptor in Health and Diseases: Foe or Friend?. Journal of Pharmacology and Experimental Therapeutics. 378(3). 251–261. 12 indexed citations
14.
Chen, Yanting, et al.. (2021). Diuretic Action of Apelin-13 Mediated by Inhibiting cAMP/PKA/sPRR Pathway. Frontiers in Physiology. 12. 642274–642274. 14 indexed citations
15.
Wang, Fei, Renfei Luo, Chang‐Jiang Zou, et al.. (2020). Soluble (pro)renin receptor treats metabolic syndrome in mice with diet-induced obesity via interaction with PPARγ. JCI Insight. 5(7). 20 indexed citations
16.
Wang, Fei, Chuanming Xu, Renfei Luo, et al.. (2019). Site-1 protease–derived soluble (pro)renin receptor targets vasopressin receptor 2 to enhance urine concentrating capability. JCI Insight. 4(7). 32 indexed citations
17.
Wang, Lei, Qing Zhu, Aihua Lu, et al.. (2017). Sodium butyrate suppresses angiotensin II-induced hypertension by inhibition of renal (pro)renin receptor and intrarenal renin–angiotensin system. Journal of Hypertension. 35(9). 1899–1908. 150 indexed citations
18.
Xu, Chuanming, et al.. (2013). Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo. Cancer Gene Therapy. 20(8). 453–460. 44 indexed citations
19.
Xu, Chuanming, Chunju Liu, Wei Huang, Shuo Tu, & Fusheng Wan. (2013). Effect of <italic>Mst1</italic> overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin <italic>in vitro</italic>. Acta Biochimica et Biophysica Sinica. 45(4). 268–279. 13 indexed citations
20.
Huang, Yü, Nancy A. Noble, J. Zhang, Chuanming Xu, & Wayne A. Border. (2007). Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney International. 72(1). 45–52. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026